Safety and efficacy of subcutaneous injection with HMI-115 versus placebo in endometriosis-associated pain in premenopausal women: a multicentre, double-blind, randomised, proof-of-concept phase 2 trial

Lan Zhu, Zi‐Jiang Chen, Haiyuan Liu, Guoyun Wang, Krzysztof Dynowski, Songying Zhang, Liehong Wang, Wenyan Wang, Xiaoqin Gan, Shunyu Hou, Ruixia Guo, Xinmei Zhang, Hongjie Ruan, Hong Xu, Shuping Zhao, Shengdong Zhang, Chongdong Liu, Yingjun Zhu, Haiyan Liu, Boqun Xu, Fang Sun, Sheng Tu, Xinli Hu, Xi Chen, Rui Xiao
In: The Lancet Obstetrics, Gynaecology, & Women's Health · 2025 · vol. 1(3) , pp. e174–e188 · doi:10.1016/j.lanogw.2025.100032 · W4415944040
OA: bronze CC0 ⤵ 2 in-corpus citations
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This Phase 2 trial evaluated the safety and efficacy of subcutaneous HMI-115 compared to placebo for treating endometriosis-associated pain in premenopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (29)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK